series-b
Stage
2
Investors
About
Maculaser develops a patented temperature-controlled retinal laser therapy that uses personalized, gentle local heating to activate natural cellular defense mechanisms for the treatment and prevention of retinal disorders such as age-related macular degeneration and macular edemas.
Explore Maculaser's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.